Visual Recognition of Allergens by Allergic Patients and/or Their Parents
REVIALL
1 other identifier
observational
440
0 countries
N/A
Brief Summary
Food allergies are constantly increasing. Peanut and nut allergies are a major cause of allergic reactions. Diagnosed patients are also at risk, because 27% of the patients that had an allergic reaction have another one in the following year with the same food, despite a real improvement in industrial products labeling. The investigators have observed in the allergy Unit that patients (and/or their family) following an elimination diet, sometimes since several years, use very strict elimination strategies. Those strategies sometimes lead to incapacities to recognize the allergens. Yet, a good identification of the allergen is the key to a successful elimination and the non-identification a known risk factor. Ferdman shown in 2006 that 27% of the patients didn't recognize the allergen there were allergic to. However, this is a US study, and geographical specificities have an impact on food consumption and culture. Food allergology needs to take those two elements into account. For example, in France, a single food can have two names. It is the case of peanut, which can be called "arachide", or more frequently "cacahuète". The goal of the study is to observe patient aptitudes to recognize peanut (and the association between the two names) and other nuts available in France and define by the European law, using a plate with various food samples in seed or in shell. Thus, patients in care at the allergy Unit of Saint Vincent Hospital of Lille (France) and their families were surveyed with a standardized procedure at the beginning of their therapeutic education and their capacity to recognize various nuts, to identify peanut ("cacahuète" or "arachide") and to associate the two words "cacahuète" and "arachide" was assessed. It is a standard procedure in therapeutic education, and the responses have been systematically entered in the medical record. The main objective of this study is to describe peanut or nut allergic patient capacity (adult, children and/or the family) to visually identify the foods there are allergic to. The secondary objective of this study is to describe the capacity of patient that describe themselves as allergic to "arachide" to associate this word to the word "cacahuète".
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2015
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2016
CompletedFirst Submitted
Initial submission to the registry
November 15, 2016
CompletedFirst Posted
Study publicly available on registry
November 17, 2016
CompletedNovember 18, 2016
November 1, 2016
3 months
November 15, 2016
November 17, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Number of patient that can visually identify the foods there are allergic to.
At inclusion
Secondary Outcomes (1)
number of patients presenting themselves as allergic to "arachide" knowing it is a synonym of "cacahuète"
at inclusion
Study Arms (1)
Nut allergic patients
Allergic patient and their family with allergy to peanut or other tree nuts that are in elimination diet.
Eligibility Criteria
Patients and their family with peanut or other nuts allergies followed in the allergy Unit of Saint Vincent Hospital of Lille (France) from 2013 to 2015, that are following an elimination diet and beginning a therapeutic education.
You may qualify if:
- Peanut or nut allergy
- Following an elimination diet since at least 3 months
- Results obtained at the beginning of a therapeutic education started from 2013 to 2015
You may not qualify if:
- Patients opposed to enter the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christine Sauvage, MD
GHICL
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 15, 2016
First Posted
November 17, 2016
Study Start
December 1, 2015
Primary Completion
March 1, 2016
Study Completion
March 1, 2016
Last Updated
November 18, 2016
Record last verified: 2016-11
Data Sharing
- IPD Sharing
- Will not share